FDA Inspection
Alza CorporationAlza Corporation – FDA Inspection, Sep 19, 2014
Record Details
This FDA Inspection record concerns Alza Corporation, with an inspection on September 19, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Alza Corporation
- Inspection Date
- September 19, 2014
- Product Type
- Drugs
View Company Profile
ID · 74c0dddc-c14b-4afd-9041-7e7519c1d267
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 897977
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.100(b)SOPs not followed / documented
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Alza Corporation
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 1, 2018 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| June 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 22, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 12, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Alza Corporation
- FDA Inspection 1039728 - 2018-02-01
- FDA Inspection 982489 - 2016-06-29
- FDA Inspection 870168 - 2014-03-14
- FDA Inspection 829365 - 2013-03-22
- FDA Inspection 777640 - 2012-04-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.